title: [22-year-old man with T-cell-lymphoma and new skin lesions].
authors.affiliation: Medizinische Universitätsklinik Knappschaftskrankenhaus, Ruhr-Universität Bochum. tobkamp@googlemail.com
authors.forename: T
authors.initials: T
authors.lastname: Kampfenkel
authors.forename: R
authors.initials: R
authors.lastname: Schroers
authors.forename: A
authors.initials: A
authors.lastname: Kreuter
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D004890:Erythema / Q000175:diagnosis* / Q000209:etiology*; D005047:Etoposide / Q000008:administration & dosage; D006358:Hot Temperature / Q000009:adverse effects*; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D020794:Receptor Protein-Tyrosine Kinases / Q000032:analysis*; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage; D055815:Young Adult
chemical_list: D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D000077548:Anaplastic Lymphoma Kinase; D020794:Receptor Protein-Tyrosine Kinases